argenx SE announced that at the Annual General Meeting of shareholders held on May 7, 2024 Dr. Brian L. Kotzin has been appointed as non-executive director to the Board of Directors for a term of four years. Dr. Kotzin brings broad medical and scientific research and development experience to the Board, supporting the Company?s innovation mission across therapeutic areas.